Dr. Mary Carter Denny, MD, MPH

Dr. Denny practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Dr. Denny's NPI, 1558688994, was assigned on April 26, 2010. Dr. Denny graduated from Tulane School of Medicine in 2010. Dr. Denny's Texas license number on file is Q1129.

Dr. Denny's primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-1400.

Dr. Denny's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dr. Denny is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Denny to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Denny practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Denny's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Denny is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Denny's licenses on file in 5 states: Texas, District of Columbia, Maryland, Virginia and Pennsylvania.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, epilepsy, head injury, mini-stroke (TIA), neck pain and spine problems, neuropathy and sleep apnea among the conditions Dr. Denny treats.

CMS data shows 408 Medicare services from Dr. Denny across 9 procedure codes in 2024, for 225 Medicare patients. Medicare paid $48,072 for them.

CMS counts 225 Medicare patients who saw Dr. Denny in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Denny's median patient age at 64, with 54% women.

In 2024, Dr. Denny wrote 353 Medicare Part D claims for 75 patients. 86% of them were for generic drugs. CMS names the drug for 212 of them, across 11 drugs with 11 or more claims each, at $56,989 in total drug cost. In 2023, CMS named 200 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Denny for performance year 2024, reported as part of a group. Dr. Denny accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Denny as offering telehealth.

Dmand AI links 10 papers to Dr. Denny, published from 2014 to 2023. 2016 was the busiest year, with 2. The most frequent topics are Stroke, Brain Ischemia and Patient Education as Topic. Dr. Denny has published most often in Neurohospitalist. Dr. Denny's most frequent co-authors are Sean Isaac Savitz, MD, Anjail Zarinah Sharrief, MD and Nathan Andrew Bicher, MD.

CMS Open Payments shows 21 general payments to Dr. Denny from 5 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 34% of the total. Abbott Laboratories paid the most, $5,881.

Dr. Denny graduated from Tulane School of Medicine in 2010.

Dr. Denny is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.